Short Term Debt - Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd (SSE:688076) - Alpha Spread
J

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076

Watchlist Manager
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076
Watchlist
Price: 68.79 CNY 12.88% Market Closed
Market Cap: 15B CNY
Have any thoughts about
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd?
Write Note

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
Short-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
Short-Term Debt Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Short-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
J
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076
Short-Term Debt
ÂĄ661.6m
CAGR 3-Years
55%
CAGR 5-Years
51%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Short-Term Debt
ÂĄ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Short-Term Debt
ÂĄ1.1B
CAGR 3-Years
15%
CAGR 5-Years
6%
CAGR 10-Years
57%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Short-Term Debt
ÂĄ249m
CAGR 3-Years
-17%
CAGR 5-Years
N/A
CAGR 10-Years
43%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Short-Term Debt
ÂĄ4.1B
CAGR 3-Years
20%
CAGR 5-Years
20%
CAGR 10-Years
21%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Short-Term Debt
ÂĄ318.9m
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd's Short-Term Debt?
Short-Term Debt
661.6m CNY

Based on the financial report for Dec 31, 2023, Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd's Short-Term Debt amounts to 661.6m CNY.

What is Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd's Short-Term Debt growth rate?
Short-Term Debt CAGR 5Y
51%

Over the last year, the Short-Term Debt growth was 74%. The average annual Short-Term Debt growth rates for Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd have been 55% over the past three years , 51% over the past five years .

Back to Top